Background: Possible effect modifiers are often considered as confounders when applying pre-defined risk-adjustment models. The aim was to provide evidence of effect modification by gender in comparative evaluations of hospitals on 30-day in-hospital mortality after acute myocardial infarction (AMI). Methods: Ninety-two Italian hospitals discharging more than 300 patients with a diagnosis of AMI during 2004 were considered. Patients discharged or transferred within 48 h of hospital admission were excluded. Comorbidities recorded in previous and current admissions were used to define patients' health status and to build the adjustment model, in which an interaction term (gender by hospital) was introduced to test the presence of effect modification. The end point was the 30-day in-hospital mortality after AMI. Results: The study population consists of 38 544 incident events of AMI from 92 Italian hospitals. Eleven hospitals showed a significant effect modification by gender. In one of them, the overall mortality rate was comparable with that of the reference category, but a significant excess risk for women was found [odds ratios (ORs) = 2.3; P < 0.01]. In 10 hospitals, the overall adjusted ORs presented a significant excess mortality compared with the benchmark: three had a significant excess mortality only among females (ranging from 230 to 370%), four only among males (ranging from 110 to 200%), and three among both genders. Conclusions: An effect modification by gender was found. The results suggest that in comparative hospital performances evaluation, stratification by gender is desirable to investigate possible differences in attitudes and practices of health services in the treatment of men and women.
Introduction
O bservational outcome studies are increasingly being used to assess and compare treatments. The main peculiarity of observational studies is their implicit lack of randomization. Methods of study design and analysis implemented to balance this characteristic are generally called 'risk adjustment'. 1, 2 These methods compensate for lack of randomization, controlling for all known selection factors that are both associated with the outcome and heterogeneously distributed between the categories of exposure under study. [3] [4] [5] Generally, in observational outcome studies, the routine procedures for systematic comparisons of providers tend to miss the detection of 'effect modifiers', and to use age and gender as variables for standard risk adjustment. 6 Such a generalized approach can lead to the lack of validity of comparative measures, generating both false-positive and false-negative results of specific comparisons and hiding or highlighting differences that do not correspond to actual events.
Concerning the outcome indicator '30-day mortality after acute myocardial infarction (AMI)', some important questions about gender and AMI mortality come from scientific literature. In particular, women between 25 and 64 years of age die from AMI two to seven times less frequently than men of the same age; however, when only hospitalized patients are considered, fatality is higher among women. Although women fare worse than men within 28 days after the onset of AMI symptoms, more men die at the beginning of that period, and thereafter the proportions progressively reverse. [7] [8] [9] [10] [11] Concerning medical interventions, women undergo less effective therapeutic procedures 12, 13 (i.e. thrombolysis) because they reach the emergency room $1 h later than men after AMI symptom onset. 14 Moreover, after admission, women tend to undergo fewer diagnostic procedures than men, and undergo them later, even after adjusting for age and specific location of AMI. 15, 16 All these findings seem to point to a specific gender role in modulating effectiveness of medical interventions and suggest that, when observational outcome studies are carried out to compare providers for 30-day mortality after AMI, a deep examination of possible effect modifiers is definitely recommended.
If an 'effect modification' occurs, hospital comparisons must be stratified by the corresponding variables. This choice is not only methodologically correct but also allows bringing out all possible differences not detectable by the overall analysis.
The aim of this article was to verify whether the relative performance, measured in terms of 30-day mortality, of each hospital in treating AMI cases can be considered as the same for males and females.
Methods

Study population
For this analysis, the National Hospital Discharge Record database was used. The first selection concerned all hospital discharge records from 1 January 2004 to 31 December 2004, with a primary or secondary diagnosis of AMI (International Classification of Disease, 9th Revision, Clinical Modification (ICD 9 CM) = 410) reported in the discharge abstract.
Then, a cohort of 98 817 incident events of AMI from 1011 hospitals was enrolled according to the following exclusion criteria:
all discharges of patients residing abroad (outside Italy); all discharges of patients <18 years or >100 years; all discharges of patients with a previous admission within 30 days, reporting a primary or secondary discharge diagnosis of AMI; all discharges of patients transferred from other hospitals; all discharges of patients discharged alive and with a hospital stay of <48 h; all discharges of patients with a secondary AMI diagnosis but with a discharge primary diagnosis different from an AMI complication diagnosis (ICD-9-CM codes = 414. 10 Some of the exclusion criteria aimed at minimizing the inclusion of false AMI and to exclude AMI that had occurred as a complication of other clinical procedures or trauma.
Multiple admissions attributable to the same event were detected using record linkage procedures with a time window of 30 days preceding each admission. Therefore, admissions of the same individuals that occurred after 30 days were considered as another episode of AMI. 17 Each episode of hospitalized AMI was attributed to the hospital of first admission.
Hospitals (n = 919) with less than 300 AMI admissions per year were considered in the analyses, but the estimated effects were not reported due to the statistical power limitations, especially analysing males and females separately.
Selection of potential confounders
Chronic comorbidities and/or severity characteristics were retrieved from the hospital information system using the discharge diagnoses of the AMI admission and the discharge diagnoses of any previous hospital admissions of the same patient during the past 12 months 18 (see Appendix for the ICD-9-CM codes defining chronic comorbidities).
Statistical analysis
The 30-day in-hospital mortality was the outcome under study. Each factor was split into condition registered during the index hospitalization and in previous hospital admissions 18 (Appendix) .
A conventional stepwise logistic procedure was performed on all potential confounders to identify their independent associations with the outcome (exclusion P = 0.05; inclusion P = 0.10). As already described in scientific literature, some chronic comorbidities, if recorded in the index admission, show a paradoxical protective effect, taking on the well-known role of 'low severity' proxy. 19 To balance this phenomenon, the same comorbidities, as recorded in previous admissions, were forced into the model as well. 20 Therefore, all variables selected by the stepwise selection procedure plus the forced ones were included in the final model.
For the purposes of this article, the epithet of 'negative' confounding was used when crude odds ratios (ORs) were found smaller than adjusted ORs; vice versa, 'positive' confounding was used when crude ORs were found larger than adjusted ORs. 21 The selected model was used to evaluate hospital-adjusted ORs, estimated by comparing each hospital to a reference category. This category was selected following two steps: in the first step, ORs for each hospital were estimated using as reference the hospital with the higher total number of AMI cases; then ORs were sorted and the group made of eight hospitals with the lowest adjusted ORs (3159 AMI episodes) represented the benchmark for evaluating the performance of each hospital in treating AMI cases. Hospital-specific crude and adjusted ORs were calculated. Finally, to test the possible effect modification of gender on hospital performances, a model including an interaction term between gender and hospitals was performed. The level of P for defining statistically significant heterogeneities was set at <0.10.
Adjusted ORs of each hospital by gender were estimated. In this analysis, the benchmark was defined on the overall population and not in the two strata (separately for males and females). This strategy allows the direct comparison of the stratum-specific ORs by hospital. All analyses were performed using the statistical packages SAS 8 and STATA 8.
Results
Results from a cohort of 38 544 incident events of AMI from 92 Italian hospitals are presented. The overall mortality rate was 12.9% (range: 7.0-26.5%).
In table 1, crude and adjusted ORs for variables included in the risk-adjustment model are reported. Age (mean = 69.5 AE 13.3 years), gender (males 64.8%) and many comorbidities were significantly associated with 30-day mortality. Differences between adjusted and crude ORs for some risk factors were found. In general, 'positive' confounding was found for almost all chronic conditions drawn out from previous hospital admissions. The only exceptions concern variables describing 'previous cardiac procedures or interventions'. On the contrary, both positive and negative confounding was found considering chronic comorbidities recorded during the AMI hospital admission. These factors showed adjusted ORs >1, confirming their known role of 'low-severity' index. 19 In table 2 , the crude and adjusted ORs by hospital are reported. The hospitals were sorted by increasing ORs. Some hospitals showed crude and adjusted ORs quite similar (differences <10%), and some others showed differences >10%, suggesting that, in the overall analysis, adjustment is necessary to control for confounding.
The interaction between gender and hospital was statistically significant (LR test: 2 = 120.7, df = 85, P < 0.001). Adjusted ORs (overall, males and females) for hospitals where effect modification by gender was detected are reported in table 3 .
Actually, several hospitals are worse than the benchmark both for males and females. To describe how the relative ranking of hospital and the estimated excess mortality can be different between males and females, the hospitals presented in table 3 were classified into four categories (A-D).
Category A includes only one hospital, whose overall crude and adjusted ORs show a slight, non-significant mortality excess (40%) compared with the reference group. From the overall analysis, this hospital should be considered 'similar to the reference group'. On the contrary, the gender-specific adjusted ORs are heterogeneous, and a significant mortality excess among females was detected (OR = 2.3, P < 0.001). No differences for males (OR = 0.8, P = 0.54) were found.
Category B includes three hospitals whose overall adjusted ORs show a significant mortality excess (from 100 to 160%). From the overall analysis, these hospitals should be considered significantly 'worse than the reference group'. The analysis of gender-specific adjusted ORs shows that they are heterogeneous, and a significant mortality excess was detected only among females (from 230 to 370%).
Category C includes four hospitals whose overall adjusted ORs show a significant mortality excess (from 70 to 110%). As for Category B, these hospitals should be considered significantly 'worse than the reference group' using the overall Gender effect on AMI mortality analysis. On the contrary, the analysis of gender-specific adjusted ORs shows that they are heterogeneous, and a significant mortality excess occurs only among males (ranging from 110 to 200%). Finally, 'D' category includes three hospitals, whose overall adjusted ORs show a significant mortality excess. In this category, a significant excess of mortality arises in both genders.
Discussion
Considering potentially detectable effect modifiers as confounders to be included in risk adjustment models represents one of the most common mistakes when running routine analysis or applying pre-defined risk adjustment models with multiple comparisons. 20, 21 This analysis, carried out for the comparative evaluation of Italian hospitals on 30-day mortality after AMI, addresses the effect modification issue for the variable gender.
Our results state that findings derived from the overall analysis could not properly describe Italian hospital performances as not all the hospitals judged significantly worse than the reference seem to be poorly performing both for males and females.
In particular, in this study, among the 84 Italian hospitals evaluated against the reference group, four hospitals show a 30-day in-hospital mortality excess after AMI only for females, but at least one of them would not have been detected in the overall adjusted analysis. Four hospitals, resulting worse than the benchmark in the overall analysis, yield a negative performance only for males. Finally, three hospitals described as significantly worse than the reference show a significant excess of mortality for both genders, but the estimated ORs are different between males and females. This is the case of trust '71' where OR for females is about three times higher than OR for males.
Labelling a hospital's performance as 'better or worse than the reference' depends strongly on the choice of the reference group. This choice is arbitrary and influenced by the aim of the study.
Choosing hospitals with the lowest adjusted mortality rates as the reference group can be useful from a public health perspective, which should aim at making hospitals' performances conform to the best ones.
As the interaction test involves sub-groups of patients identified by the potential effect modifier, to overcome the problem of the P-value sensitiveness to the number of observations, the P-level for defining statistically significant heterogeneities was set at P < 0.10. Although the number of hospitals found with a significant interaction term is included in the Poisson confidence interval of the expected value (n = 8), in some cases the difference in OR between males and females is so high that they deserve attention and encourage a deeper analysis.
Evidence has consistently shown that clinical characteristics of AMI are heterogeneous between genders. International scientific literature describes differences in the attitudes and practices of health services in treating men and women. The findings suggest that women survival rates after AMI are lower than those described in men, because women are not offered the same therapeutic interventions as men. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] The occurrence of in-hospital death within 30 days after AMI does not completely represent the phenomenon, being limited only to events occurring during a hospital admission. Nevertheless, the outcome under study should be considered as a proxy measure of the effectiveness of the whole process of diagnosis and treatment of AMI patients after their hospital admission. From this point of view, considering gender as a possible effect modifier can help to focus on organizational, structural and social factors affecting men and women with AMI differently, although it is beyond the scope of this article to investigate which specific structural and organizational characteristics at the hospital level are associated with 30-day mortality after AMI.
For this analysis, a logistic regression model has been used. In recent years, several publications in medical and health service research literature have advocated the use of hierarchical statistical models to analyse nested data. The main criticism addressed to the conventional logistic regression approach is that it can wrongly increase the statistical significance for variables measured at hospital level as compared with the multilevel model. 22, 23 As this study focuses on the ORs estimates more than their statistical significance, a conventional logistic regression model has been chosen for its wider spread and comprehensibility.
All information used in this analysis is from discharge records collected by the health information system of the National Health System. Although the use of administrative data for evaluating health services is becoming more common, 24, 25 limitations in their completeness and reliability can lead to misclassifications. These limitations apply to all diagnoses relevant for the analysis, including the diagnosis of AMI and those classifying comorbidities used for risk adjustment. In any case, the direction and entity of biases on the measures of association could not be directly assessed. Moreover, being the only severity data available from discharge records of patients with chronic diseases, the actual clinical severity of AMI at the time of hospital admission could not be completely assessed in this study. An important problem to consider is that severity scores based on administrative data may include complications that develop after admission. For this reason, it is desirable to use a diagnosis-type indicator to exclude complications from the definition of comorbidities (i.e. shock). 26, 27 Finally, although studies on the validity of diagnoses of AMI in Italian discharge records estimate high levels of sensitivity and specificity, 28 it cannot be definitively excluded that some of the heterogeneity of mortality observed in this study are actually caused by unmeasured confounders. This is the case of variables like serum creatinine, and emergency conditions, known to affect mortality after AMI, but not recorded in the Italian administrative database.
Besides all the described weaknesses, this analysis states that 'effect modification' must be considered as a possible occurrence in the study population. In observational outcome studies, when 'effect modification' occurs, hospital comparisons must be stratified by the corresponding variables. This choice is not only methodologically correct but also allows to describe what actually happens and highlights some hidden hospital problems. From a public health point of view, it means having scientific tools to address targeted interventions aimed at solving specific problems in specific settings. This could be the case of an auditing programme that local health authorities could implement in hospitals judged to have a good performance on the whole, but found out poorly performing in some population sub-groups. On the contrary, for hospitals where the 'effect modification' has not been detected, the relevant adjusted measure of comparison (i.e. OR) should be provided at aggregate levels.
Because all study populations are finite, both control of confounding and detection of effect modification will inevitably reflect the trade-off between validity and parsimony. In designing the study, the amount of bias that needs to be adjusted, and the effect modifiers that must be screened, must be clearly identified. These choices should be made taking into account not only the characteristics and dimensions of the study and available evidence from previous studies but also more importantly the costs and benefits in terms of correct and incorrect results for the purpose of making comparisons. This is particularly relevant when the results are published and the publication of data can have important consequences not only for health providers and professionals but also for patients and the whole society. 
